Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's disease.
Blin, J.; Ivanoiu, Adrian; De Volder, Anne; Michel, Christian; Bol, Anne; Verellen, Christine; Seron, Xavier; Duprez, Thierry; Laterre, E. Christian; Psychopharmacology, 1998, vol. 136, issue 3, p 256, ISSN 00333158. ISBN 00333158.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef